Login / Signup

Efficacy of secukinumab and adalimumab in patients with psoriatic arthritis and concomitant moderate-to-severe plaque psoriasis: results from EXCEED, a randomized, double-blind head-to-head monotherapy study.

A B GottliebJ F MerolaKristian ReichF BehrensP NashChristopher Ernest Maitland GriffithsW BaoP PelletL PricopI B McInnes
Published in: The British journal of dermatology (2021)
This prespecified analysis in PsA patients with concomitant moderate-to-severe plaque psoriasis in the EXCEED study provides further evidence that IL-17 inhibitors offer a comprehensive biological treatment to manage the concomitant features of psoriasis and PsA.
Keyphrases
  • prostate cancer
  • coronary artery disease
  • clinical trial
  • early onset
  • double blind
  • high intensity
  • randomized controlled trial
  • atopic dermatitis
  • ankylosing spondylitis
  • optic nerve
  • data analysis